|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1993-7-19
|
|
pubmed:abstractText |
A new hypoxic cell sensitizer has been synthesized; this is a 2-nitroimidazole nucleoside analog having erythritol as a sugar moiety at the N-1 position of the imidazole ring (RP-343). Its possibility as a potent hypoxic cell sensitizer was compared with those of RP-170 and etanidazole.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
433-43
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8514541-Animals,
pubmed-meshheading:8514541-Cell Hypoxia,
pubmed-meshheading:8514541-Cell Survival,
pubmed-meshheading:8514541-Dogs,
pubmed-meshheading:8514541-Dose-Response Relationship, Drug,
pubmed-meshheading:8514541-Etanidazole,
pubmed-meshheading:8514541-Female,
pubmed-meshheading:8514541-Injections, Intravenous,
pubmed-meshheading:8514541-Mice,
pubmed-meshheading:8514541-Mice, Inbred BALB C,
pubmed-meshheading:8514541-Mice, Inbred C3H,
pubmed-meshheading:8514541-Neoplasms, Experimental,
pubmed-meshheading:8514541-Nitroimidazoles,
pubmed-meshheading:8514541-Nucleosides,
pubmed-meshheading:8514541-Radiation-Sensitizing Agents
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
|
|
pubmed:affiliation |
Department of Radiation Oncology, School of Medicine, Tokai University, Isehara, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro
|
